Cardiology
CHF
More in CHF
Recent developments of interest in cardiovascular medicine
Randomized trial suggests benefit is largely in those with 40-60% ejection fraction
A case for monitoring global longitudinal strain despite normal LVEF
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
TVT registry compares outcomes with Evolut FX and Pro+
Approval study analysis suggests best practices
But procedure no less effective for this higher risk group, COAPT trial post hoc analysis shows
Benefits similar across anatomical complexity, advanced heart failure in post-marketing studies
Future treatments don't have to be limited to slowing disease, case series suggests
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
SGLT1/SGLT2 inhibitor approved on the basis of SOLOIST-WHF, SCORED trials
U.S. guidelines finally address LBB pacing, His bundle pacing
